| Literature DB >> 31372118 |
Aleksandar Dobrosavljevic1, Snezana Rakic2, Sladjana Mihajlovic3.
Abstract
OBJECTIVES: The purpose of this study was to examine the potential impact of severe Ovarian hyper stimulation syndrome (OHSS) on the risk of preterm birth. Severe ovarian hyperstimulation syndrome is a serious complication in the methods of in vitro fertilization. The pathophysiology of this process is not clear enough and the treatment is symptomatic. Human chorionic gonadotropin (h-CG) is the most important known cause of this condition. Findings of other authors often do not match when it comes to complications that may occur in pregnancy.Entities:
Keywords: IVF/ICSI; Ovarian hyper stimulation syndrome; Preterm birth
Year: 2019 PMID: 31372118 PMCID: PMC6659057 DOI: 10.12669/pjms.35.4.145
Source DB: PubMed Journal: Pak J Med Sci ISSN: 1681-715X Impact factor: 1.088
Preterm labor (number (%)).
| Preterm labor | OHSS (n=50) | Control Group (n=59) |
|---|---|---|
| <34 | 17 (34.0%) | 4 (6.8%) |
| <37 | 28 (56.0%) | 18 (30.5%) |
| >=37 | 22 (44.0%) | 41 (69.5%) |
There is statistically significant difference between preterm labor in the OHSS and control group (<34 w.g.; p=0.000); (< 37 w.g.; p=0.011). In the OHSS group we have as much as 34% of children who were born before 34th week of gestation but in the control group only 6.8%.
Preterm labor (number (%)) – as per pregnancy type.
| Preterm labor | Singleton pregnancy | Twin pregnancy | ||
|---|---|---|---|---|
| OHSS (n=30) | Control group (n=38) | OHSS (n=19) | Control group (n=21) | |
| Yes | 12 (40.0%) | 4 (10.5%) | 16 (84.2%) | 14 (66.7%) |
| No | 18 (60.0%) | 34 (89.5%) | 3 (15.8%) | 7 (33.3%) |
There is statistically significant difference in preterm labor between the OHSS and control group when only singleton pregnancy is considered (p=0.013), but not in twin pregnancy group (p=0.454).
Newborns weight (mean value ± standard deviation or number (%)).
| Body weight | p | ||||
|---|---|---|---|---|---|
| <1500 | 1500-2500 | >2500 | |||
| Whole group | OHSS | 13 (19.1%) | 31 (45.6%) | 24 (35.3%) | 0.000 |
| Control | 3 (3.8%) | 20 (25.0%) | 57 (71.3%) | ||
| Singleton | OHSS | 6 (20.0%) | 5 (16.7%) | 19 (63.3%) | 0.003 |
| Control | 0 (0%) | 2 (5.3%) | 36 (94.7%) | ||
| Twin | OHSS | 7 (18.4%) | 26 (68.4%) | 5 (13.2%) | 0.002 |
| Control | 3 (7.1%) | 18 (42.9%) | 21 (50.0%) | ||
There is statistically significant difference between OHSS and control group in weight. (p=0.000) In the OHSS group we have as much as 19.1% of children below 1500 gr. but in the control group only 3.8%.
Patient’s characteristics (mean value ± standard deviation or number (%)).
| OHSS (n=50) | Control group (n=59) | |
|---|---|---|
| Age (years) | 32.47±3.92 | 33.60±3.54 |
| BMI (kg/m2) | 22.47±314 | 21.92±2.44 |
| PCOS | 14 (28.0%) | 11(18.6%) |
| Tubal | 7 (14.0%) | 4(6.7%) |
| Endometriosis | 5 (10.0%) | 6(10.1%) |
| Anovulation | 1 (2.0%) | 0 |
| Male | 8 (16.0%) | 19(32.2%) |
| Unexplained | 15 (30.0%) | 19(32.2%) |
| Number of obtained oocytes | 11.93±3.48 | 8.17±2.453 |
| E2 values on a day for HCG (pg/ml) | 2678.82 ±719.70 pg/ml | 1702.90±700 |
| Protocol with antagonists | 15 (30.0%) | 34 (57.6%) |
| Long protocol with agonists | 35 (70.0%) | 25 (42.37%) |
| Total gonadotropin dose | 1759.78±395.09 | 2325.13±767.87 |
Statistically significant difference between the two categories occurs in a number of obtained oocytes, E2 values, total gonadotropin dose (p<0.000), as well as in protocols (p=0.014).
Demographic and clinical characteristics (mean value ± standard deviation or number (%)) – singleton pregnancy.
| OHSS (n=31) | Control group (n=38) | |
|---|---|---|
| Age (years) | 31.44±3.46 | 34.14±3.17 |
| BMI (kg/m2) | 22.08±2.95 | 22.12±2.59 |
| PCOS | 8 (25./8%) | 8(21.0%) |
| Tubal | 4 (12.9%) | 4(10.5%) |
| Endometriosis | 2 (6.5%) | 3(7.9%) |
| Anovulation | 1(3.2%) | |
| Male | 3 (9.7%) | 13 (34.2%) |
| Unexplained | 13 (41.9%) | 10 (26.3%) |
| Number of obtained oocytes | 12.31±3.83 | 8.3±2.71 |
| E2 values on a day for HCG (pg/ml) | 2692.70±788.23 | 1815.49±794.97 |
| Protocol with antagonists | 10 (32.2%) | 25(59.5%) |
| Long protocol with agonists | 21 (67.7%) | 17(40.5%) |
| Total gonadotropin dose | 1869±420.63 | 2442.95±765.95 |
As in the previous case, significant difference occurs in a number of obtained oocytes, E2 values, total gonadotropin dose (p<0.001).
Demographic and clinical characteristics (mean value ± standard deviation or number (%)) – twin pregnancy.
| OHSS (n=19) | Control group (n=21) | |
|---|---|---|
| Age (years) | 34.21±4.10 | 32.52±4.04 |
| BMI (kg/m2) | 23.13 | 21.51±2.11 |
| PCOS | 6 (31.6%) | 3 (14.3%) |
| Tubal | 3 (15.8%) | 0 |
| Endometriosis | 3 (15.8%) | 3 (14.3%) |
| Anovulation | 0 | 0 |
| Male | 5 (26.3%) | 6 (28.6%) |
| Unexplained | 2 (10.5%) | 9 (42.9%) |
| Number of obtrained oocytes | 11.84±3.54 | 7.90±2.20 |
| E2 values on a day for HCG (pg/ml) | 2655.43±606.50 | 1771.19±504.34 |
| Antagonists | 5 (26.3%) | 10(47.6%) |
| Agonists | 14 (73.7%) | 11(52.4%) |
| Total gonadotropin dose | 1817.50±406.37 | 2532.47±756.94 |
Statistically significant difference occurs in a number of obtained oocytes (p=0.002), in E2 values, total gonadotropin dose (p≤0.001) as well as in protocols (p=0.010).